Biological targeting compositions and methods of using the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 3, 2012
Grant Date -
Feb 18, 2010
app pub date -
Aug 13, 2008
filing date -
Aug 13, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully